trending Market Intelligence /marketintelligence/en/news-insights/trending/x12excv9azr6osdau_xp4g2 content esgSubNav
In This List

Ampio Pharmaceuticals chief scientific officer to retire

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Ampio Pharmaceuticals chief scientific officer to retire

Ampio Pharmaceuticals Inc. said David Bar-Or will retire as chief scientific officer, effective Sept. 30.

Bar-Or will remain on the Englewood, Colo.-based biopharmaceutical company's board.

He said he plans to do some projects at the Trauma Research Center where he serves as research director for eight medical institutions.